微博
加入微博一起分享新鲜事
登录
|
注册
140
Alpelisib: A Well-Tolerated Treatment Option for Patients with HR-Positive, HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer https://journal.hep.com.cn/gmg/EN/10.1055/s-0041-1736239
请登录并选择要私信的好友
300
Alpelisib: A Well-Tolerated Treatment Option for Patients with HR-Positive, HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer https://journal.hep.com.cn/gmg/EN/10.1055/s-0041-1736239
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博,请稍候